Patients’ Preference Between DPP4i and SGLT2i for Type 2 Diabetes Treatment: A Cross-Sectional Evaluation

PURPOSE: Despite newer type 2 diabetes (T2D) medications, patients do not always achieve metabolic targets, remaining at risk for cardiorenal complications. Therapeutic decisions are generally made by the healthcare team without considering patients’ preferences. We aimed to evaluate patients’ T2D t...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa Gil, José Esteban, Garnica Cuéllar, Juan Carlos, Perez Terns, Paula, Ferreira-Hermosillo, Aldo, Cetina Canto, José Antonio, Garduño Perez, Ángel Alfonso, Mendoza Martínez, Pedro, Rista, Lucas, Sosa-Caballero, Alejandro, Vázquez-Mendez, Estefanía, Tejado Gallegos, Luis Fernando, Chen, Hungta, Elizalde, Agustina, Tomatis, Virginia B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112794/
https://www.ncbi.nlm.nih.gov/pubmed/35592774
http://dx.doi.org/10.2147/PPA.S355638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112794/
https://www.ncbi.nlm.nih.gov/pubmed/35592774
http://dx.doi.org/10.2147/PPA.S355638

Ejemplares similares